June 23, 2009

Feehally   Hogg

IgA Nephropathy: Time to Change Our Approach?    John Feehally, MD, and Ronald J. Hogg, MD (ASN Renal Week Clinical Nephrology Conference, November, 2008.) Feehally: All cases of IgAN truly are not the same. How can we better understand disease variation? Predict prognosis? Choose the best treatment strategy? How does age affect presentation? Geographic location? What do we know about crescentic IGAN? Secondary disease? What are the data regarding recurrence of IgAN in transplants? Is microscopic hematuria only a benign presentation? Do we really know that IGAN is a single disease? How do we choose the best treatment for each of the variant clinical presentations? Does tonsillectomy work? What is the role for fish oil, BP control, renin-angiotensin blockade, and corticosteroids and immunosuppression? Hogg: What is the role for steroids and immunosuppression in IgAN? When should these drugs be used initially? When as a second line of treatment? Are all IS drugs equal in potency and/or effect? Does response to an IS drug depend on dosage, duration, or method of administration? To what extent are these questions answerable with the present data?

Did you miss these recent slide/audio lectures? Advances in CKD SLIDE/AUDIO LIST (ADVANCES in CKD 2009) Part 3 (8 talks with panel discussions) New insights into lipid metabolism in CKD: what are the practical implications? George Kaysen, MD Nocturnal dialysis: evidence and practicality John Burkart, MD Salt, overhydration, the sympathetic nervous system and the heart Christopher Chan, MD Evolution of guidelines from opinion to evidence: what has been the practical result? Katrin Uhlig, MD Keynote address: Aldosterone - Extracellular Volume Interaction CKD Philip Klemmer, MD Cardiac disease in the dialysis patient: Good - Better - Best Clinical Practice Hannelore Hampl, MD How to dialyze the acutely ill kidney patient taking into account diagnostic predictors, dose, fluids, temperature and extracorporeal systems Claudio Ronco, MD ACE inhibitors or ARBs to preserve the peritoneal membrane - a novel concept John Burkart, MD CKD Care and Your Practice Culture: Improve Your Performance! (Part 2) SLIDE/AUDIO LIST (RPA 2009 (free to RPA members) Harris   Velez   Mecum   Shortliffe   Maddux   Coeytaux   Kliger       (7 talks from Sessions III, IV and V) Brian Ling Lecture: The Role of the Medical Home Model with Nephrologists Jeffrey Harris, MD Understanding PQRI Ruben Velez, MD How Does Your Practice Compare? RPA's 2007 Benchmarking Survey Suzanne Mecum, CPA, FACMPED John Dickmeyer Lecture: Computerized Clinical Decision Support Systems Edward Shortliffe, MD, PhD The Effect of the Economic Stimulus Package on Your Nephrology Practice Franklin Maddux, MD Lessons from the RPA Advanced CKD Toolkit Fieldtest Remy Coeytaux, MD The New Conditions of Coverage: Requirements for Quality Assessment and Performance Improvement and Medical Directors Alan Kliger, MD

HDCN home /about our site / subscribe to key zone / register for free zone
update email address / subscription status / forget your password?